Figure 3

Receiver operating characteristic curves of HA for the prediction of significant fibrosis (F2-F4), severe fibrosis (F3F4), and cirrhosis (F4) in the validation set.
Receiver operating characteristic curves of HA for the prediction of significant fibrosis (F2-F4), severe fibrosis (F3F4), and cirrhosis (F4) in the validation set.